EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of

EQSAdhoc Takeda Pharmaceutical Company Limited Key word Forecast Takeda Pharmaceutical Company Limited Notice of the Revised Forecast of Consolidated Financials for FY2023 26Oct2023 0800 CETCEST Disc

Related Keywords

Japan , Ireland , Osaka , United States , Irish , Brendan Jennings , Christopher Oreilly , Constant Exchange Rate , Takeda Pharmaceutical Company Limited , Revised Forecast , Consolidated Financials , Full Year Consolidated Financials , Fiscal Year Ending March , Operating Profit , Irish Revenue Commissioners , Score Revenue , Core Operating Profit , Eqsadhoc , Makeda , Harmaceutical , Company , Imited , Forecast , Notice , Evised , Onsolidated , Financials , Etcest , Disclosure , Inside , Information , Article , Regulation , Ransmitted , Service , Group , Ass ,